Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124080833 | 12408083 | 3 | F | 20160503 | 20160809 | 20160526 | 20160815 | EXP | DE-ROCHE-1763844 | ROCHE | 76.28 | YR | F | Y | 62.00000 | KG | 20160815 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124080833 | 12408083 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | TOGETHER WITH BENDAMUSTINE. | U | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
| 124080833 | 12408083 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | TOGETHER WITH BENDAMUSTINE. | U | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
| 124080833 | 12408083 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | TOGETHER WITH BENDAMUSTINE. | U | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
| 124080833 | 12408083 | 4 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | TOGETHER WITH BENDAMUSTINE. | U | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
| 124080833 | 12408083 | 5 | SS | Bendamustine | BENDAMUSTINE | 1 | Unknown | U | 0 | ||||||||||
| 124080833 | 12408083 | 6 | SS | Bendamustine | BENDAMUSTINE | 1 | Unknown | U | 0 | ||||||||||
| 124080833 | 12408083 | 7 | SS | Bendamustine | BENDAMUSTINE | 1 | Unknown | U | 0 | ||||||||||
| 124080833 | 12408083 | 8 | SS | Bendamustine | BENDAMUSTINE | 1 | Unknown | U | 0 | ||||||||||
| 124080833 | 12408083 | 9 | C | VINCRISTINE | VINCRISTINE | 1 | Unknown | PREPHASE TREATMENT | 0 | 1 | G | ||||||||
| 124080833 | 12408083 | 10 | C | PREDNISOLON | PREDNISOLONE | 1 | Intravenous (not otherwise specified) | PREPHASE TREATMENT. | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124080833 | 12408083 | 1 | Non-Hodgkin's lymphoma |
| 124080833 | 12408083 | 5 | Non-Hodgkin's lymphoma |
| 124080833 | 12408083 | 9 | Non-Hodgkin's lymphoma |
| 124080833 | 12408083 | 10 | Non-Hodgkin's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124080833 | 12408083 | DE |
| 124080833 | 12408083 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124080833 | 12408083 | Progressive multifocal leukoencephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124080833 | 12408083 | 1 | 20160106 | 0 | ||
| 124080833 | 12408083 | 2 | 20160203 | 0 | ||
| 124080833 | 12408083 | 3 | 20160303 | 0 | ||
| 124080833 | 12408083 | 4 | 20160330 | 20160405 | 0 | |
| 124080833 | 12408083 | 5 | 20160106 | 0 | ||
| 124080833 | 12408083 | 6 | 20160203 | 0 | ||
| 124080833 | 12408083 | 7 | 20160303 | 0 | ||
| 124080833 | 12408083 | 8 | 20160330 | 0 | ||
| 124080833 | 12408083 | 9 | 20160104 | 20160104 | 0 | |
| 124080833 | 12408083 | 10 | 20160104 | 20160104 | 0 |